Want to see TSE:DHB full AI Analyst Report?
Delivra Health Brands (DHB) AI Stock Analysis
Delivra Health Brands
(TSXV:DHB)
The score is weighed down primarily by weak financial performance (declining TTM revenue, ongoing net losses, and negative free cash flow) and bearish technical trends (below all key moving averages with negative MACD). Valuation provides limited support because the negative P/E reflects losses and no dividend yield is available.
Delivra Health Brands (DHB) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 2.34M
- Dividend Yield
- ―
- Average Volume (3M)
- 35.25K
- Price to Earnings (P/E)
- -2.3
- Beta (1Y)
- 1.93
- Revenue Growth
- -35.46%
- EPS Growth
- -85.82%
- Country
- Canada
- Employees
- 22
- Sector
- General
- Sector Strength
- 55
- Industry
- Drug Manufacturers - Specialty & Generic
Delivra Health Brands Business Overview & Revenue Model
Company Description
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's pro...
How the Company Makes Money
DHB makes money by generating revenue from the sale of its consumer health and wellness products to customers through its distribution network. Key revenue streams are primarily tied to product sales (e.g., wholesale/retail sell-in and related distri...
Delivra Health Brands Financial Statement Overview
Summary
Financial quality is below average: TTM revenue fell materially (-14.1%), the company remains unprofitable (net margin around -9%), and cash generation is weak with negative operating cash flow and free cash flow. The balance sheet is moderately levered (debt-to-equity ~0.79) with positive equity, but shrinking equity and ongoing losses increase execution risk.
Income Statement
38NegativeBalance Sheet
53NeutralCash Flow
30Negative| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.24M | 13.37M | 12.38M | 9.79M | 8.14M | 7.96M |
| Gross Profit | 5.12M | 6.78M | 6.40M | 3.49M | 485.00K | -297.00K |
| EBITDA | -507.00K | 427.00K | 2.35M | 1.40M | -4.25M | -7.04M |
| Net Income | -1.01M | -1.19M | 876.00K | -184.00K | -7.01M | -28.54M |
Balance Sheet | ||||||
| Total Assets | 7.13M | 9.61M | 10.05M | 10.56M | 11.59M | 19.06M |
| Cash, Cash Equivalents and Short-Term Investments | 2.64M | 3.30M | 4.20M | 2.73M | 1.11M | 5.14M |
| Total Debt | 2.33M | 2.11M | 2.03M | 1.96M | 2.11M | 2.16M |
| Total Liabilities | 4.18M | 5.37M | 4.86M | 7.17M | 8.21M | 9.09M |
| Stockholders Equity | 2.94M | 4.24M | 5.19M | 3.39M | 3.37M | 9.98M |
Cash Flow | ||||||
| Free Cash Flow | -325.00K | -754.00K | 756.00K | -1.13M | -4.46M | -9.68M |
| Operating Cash Flow | -325.00K | -754.00K | 756.00K | -1.09M | -4.44M | -9.65M |
| Investing Cash Flow | 0 | 0 | 11.00K | 2.91M | 1.35M | 12.27M |
| Financing Cash Flow | -17.00K | -36.00K | 594.00K | -255.00K | -309.00K | 446.00K |
Delivra Health Brands Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DHB, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.10, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 40.20 is Neutral, neither overbought nor oversold. The STOCH value of 6.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:DHB.
Delivra Health Brands Peers Comparison
Overall Rating
TSE:TGIF45Neutral- TSE:DHB41Neutral
TSE:CDVA40.9Neutral
TSE:PCLO24Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TSE:TGIF | 45Neutral | CAD 5.21M | 6.25 | -11.60% | ― | -4.90% | ― |
| TSE:DHB | 41Neutral | CAD 2.34M | -2.31 | -26.42% | ― | -35.46% | -85.82% |
| TSE:CDVA | 41Neutral | CAD 2.75M | -1.04 | 43.99% | ― | -6.27% | 44.49% |
| TSE:PCLO | 24Underperform | CAD 9.34M | -2.67 | 28.59% | ― | 0.90% | 57.73% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:DHB | Delivra Health Brands Inc. | 0.07 | -0.21 | -74.14% | |
| TSE:TGIF | 1933 Industries, Inc. | 0.01 | 0.00 | 0.00% | |
| TSE:PCLO | Pharmacielo | 0.05 | 0.01 | 11.11% | |
| TSE:CDVA | CordovaCann Corp | 0.03 | -0.00 | -16.67% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jun 11, 2026